Trial NCT00447226

View at ClinicalTrials.gov 
Org. Study IDs: LPT108741

Last trial update was posted on 2012-06-12

MeSH Interventions

Lapatinib

MeSH Conditions


Other Conditions

Cancer

Stopping Reasons

The study had failed to meet the primary objective of tumor response rate at 12 weeks from first dose.

Limitations And Caveats

Study terminated prematurely: preliminary assessment (prompted by low screening/enrollment rates) showed primary objective of tumor response rate not met. Also unable to test primary treatment comparison after randomization following SD at 12 wks.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID